Trial intelligence / Profile preview

ACES: Perindopril and Exercise for Seniors with Hypertension

NCT03295734Phase 2Completed

Sponsor
University of Alabama at Birmingham
Start
May 2018
Primary completion
Sep 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of perindopril in hypertension (HTN), sponsored by University of Alabama at Birmingham. Started May 2018; status: completed.

02

Drugs

perindopril
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT03295734.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03295734.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call